Colorectal Cancer Outcomes with NOSES Surgery
Part of Cancer, Digestive system clinical trials.
This study tracks patients with colon or rectal cancer who have a special type of surgery called natural orifice specimen extraction surgery (NOSES). The goal is to see how well patients do short-term and long-term after this procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with a primary malignant tumor (cancer) in your colon or rectum. This is confirmed by a biopsy or pathology report.
- The surgery you had or will have must be a type called 'natural orifice specimen extraction surgery' (NOSES). This means the tumor is taken out through a natural opening, like the anus or vagina, instead of through a large cut in the belly.
- If the final pathology report says the tumor is not a primary colon or rectal cancer, you cannot participate.
- If your surgery does not match the NOSES definition (for example, it requires a large abdominal incision), you cannot participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to remove left-sided colon cancer and take the specimen out through the anus (without a large external incision). It may help find which approach is safer and more effective for curing Stage I–III disease.
This study tests whether taking nutritional supplements before minimally invasive colorectal cancer surgery helps improve recovery and outcomes. Researchers want to see if extra nutrition helps your body heal better after the operation.
This trial compares surgery versus an endoscopic procedure for people who had a colon polyp removed but some cancer cells may still be present at the edges. The goal is to see which approach leads to better outcomes and fewer side effects for early-stage colon cancer.
This study looks at factors that affect outcomes in people with colorectal cancer who have surgery as their main treatment. It aims to help doctors understand how to improve care.
This study looks at how well surgery works for people with colorectal cancer that has not spread to distant organs. It mainly includes patients who can have the tumor completely removed and accurately staged using lymph node samples.
This trial is for people with certain types of gastrointestinal cancers that have a genetic feature called MSI-H/dMMR or POLE mutation. It looks at whether, after immunotherapy, you can avoid surgery or have a less invasive procedure instead, such as watching and waiting, endoscopic removal, or limited surgery.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.